Skeletal muscle PGC-1a is required for maintaining an acute LPS-induced TNFa response

Jesper Olesen, Signe Larsson, Ninna Iversen, Simi Yousafzai, Ylva Hellsten, Henriette Pilegaard

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

26 Citationer (Scopus)
1878 Downloads (Pure)

Abstract

Many lifestyle-related diseases are associated with low-grade inflammation and peroxisome proliferator activated receptor ¿ coactivator (PGC)-1a has been suggested to be protective against low-grade inflammation. However, whether these anti-inflammatory properties affect acute inflammation is not known. The aim of the present study was therefore to investigate the role of muscle PGC-1a in acute inflammation. Quadriceps muscles were removed from 10-week old whole body PGC-1a knockout (KO), muscle specific PGC-1a KO (MKO) and muscle-specific PGC-1a overexpression mice (TG), 2 hours after an intraperitoneal injection of either 0.8 µg LPS/g body weight or saline. Basal TNFa mRNA content was lower in skeletal muscle of whole body PGC-1a KO mice and in accordance TG mice showed increased TNFa mRNA and protein level relative to WT, indicating a possible PGC-1a mediated regulation of TNFa. Basal p65 phosphorylation was increased in TG mice possibly explaining the elevated TNFa expression in these mice. Systemically, TG mice had reduced basal plasma TNFa levels compared with WT suggesting a protective effect against systemic low-grade inflammation in these animals. While TG mice reached similar TNFa levels as WT and showed more marked induction in plasma TNFa than WT after LPS injection, MKO PGC-1a mice had a reduced plasma TNFa and skeletal muscle TNFa mRNA response to LPS. In conclusion, the present findings suggest that PGC-1a enhances basal TNFa expression in skeletal muscle and indicate that PGC-1a does not exert anti-inflammatory effects during acute inflammation. Lack of skeletal muscle PGC-1a seems however to impair the acute TNFa response, which may reflect a phenotype more susceptible to infections as also observed in type 2 diabetes patients.
OriginalsprogEngelsk
TidsskriftP L o S One
Vol/bind7
Udgave nummer2
Sider (fra-til)e32222
Antal sider9
ISSN1932-6203
DOI
StatusUdgivet - 2012

Bibliografisk note

CURIS 2012 5200 033

Citationsformater